Frequent expression of human Thy-1 antigen on pre-B cell acute lymphoblastic leukemia with t(9;22)

International Journal of Hematology

Volumn 67, Issue 4, 1998, Pages 369-378

  Takahashi, Takahiro ^a   Mizutani, Minoru ^a   Miwa, Hiroshi ^a   Katayama, Naoyuki ^a   Nishii, Kazuhiro ^a   Shikami, Masato ^a   Yamaguchi, Motoko ^a   Hiroshi Shiku, ^a   Kamada, Nanao ^b   Kita, Kenkichi ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Res Inst Nucl Med Biol   (Japan)

Author keywords

Cell cycle; Pre B ALL; T(9; 22); Thy 1

Indexed keywords

BCR ABL PROTEIN; THY 1 ANTIGEN; TRANSCRIPTION FACTOR GATA 2; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; CELL POPULATION; CELL PROLIFERATION; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION 9; FEMALE; FLUOROGRAPHY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPHENOTYPING; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031868191     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0925-5710(98)00021-8     Document Type: Article

References (24)

1. Low M.G., Kincade P.W. Phosphatidylinositol is the membrane-anchoring domain of the Thy-1 glycoprotein. Nature. 318:1985;62-64.
2. Williams D.E., Boswell H.S., Floyd A.D., Broxmeyer H.E. Pluripotential hematopoietic stem cells in post-5-fluorouracil murine bone marrow express the thy-1 antigen. J Immunol. 135:1985;1004-1011.
3. Baum C.M., Weissman I.L., Tsukamoto A.S., Buckle A.M., Peault B. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA. 89:1992;2804-2808.
4. Craig W., Kay R., Culter R.L., Landsdrop P.M. Expression of Thy-1 on human hematopoietic progenitor cells. J Exp Med. 177:1993;1331-1342.
5. Mayani H., Landsdorp P.M. Thy-1 expression is linked to functional properties of primitive hematopoietic progenitor cells from human umbilical cord blood. Blood. 83:1994;2410-2417.
6. Greaves M.F. Differentiation-linked leukemogenesis in lymphocytes. Science. 234:1986;697-704.
7. Lamkin T., Brooks J., Annett G., Roberts W., Weinberg K. Immunophenotypic differences between putative hematopoietic stem cells and childhood B-cell precursor acute lymphoblastic leukemia cells. Leukemia. 8:1994;1871-1878.
8. Holden J.T., Geller R.B., Farhi D.C.et al. Characterization of Thy-1 (CDw90) expression in CD34+ acute leukemia. Blood. 86:1995;60-65.
9. Campos L., Guyotat D. Expression of Thy-1 antigen (CDw90) on adult acute leukemia blast cells. Blood. 87:1996;413-414.
10. Kita K., Nakase K., Miwa H.et al. Phenotypical characteristics ofacute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34. Blood. 80:1992;470-477.
11. Miwa H., Kita K., Nishii K.et al. Expression of MDR1 gene in acute leukemia cells: association with CD7+ acute myeloblastic leukemia/acute lymphoblastic leukemia. Blood. 82:1993;3445-3451.
12. Fainstein E., Einat M., Gokkel E.et al. Nucleotide sequence analysis of human abl and bcr-abl cDNAs. Oncogene. 4:1989;1477-1481.
13. Lifshitz B., Fainstein E., Marcelle C.et al. bcr genes and transcripts. Oncogene. 2:1988;113-117.
14. Seki T., Spurr N., Obata F., Goyert S., Goodfellow P., Silver J. The human Thy-1 gene: structure and chromosomal location. Proc Natl Acad Sci USA. 82:1985;6657-6661.
15. Dofman D.M., Wilson D.B., Bruns G.P., Orkin S.H. Human transcriptional factor GATA-2. J Biol Chem. 267:1992;1279-1285.
16. Begley C.G., Aplan P.D., Denning S.M., Haynes B.F., Waldmann T.A., Kirsch I.R. The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. Proc Natl Acad Sci USA. 86:1989;10128-10132.
17. Nakajima-Iijima S., Hamada H., Reddy P., Kakunaga T. Molecular structure of the cytoplasmic β-actin gene: interspecies homology of sequences in the intron. Proc Natl Acad Sci USA. 82:1985;6133-6137.
18. Asou H., Tashiro S., Hanamoto K., Otsuji A., Kita K., Kamada N. Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosomal translocation. Blood. 77:1991;2031-2036.
19. Nadler L.M., Korsmeyer S.J., Anderson K.C.et al. Cell origin of non-T cell acute lymphoblastic leukemia: a model for discrete stages of neoplastic and normal pre-B cell differentiation. J Clin Invest. 74:1984;332-340.
20. Fleming W.H., Alpern E.J., Uchida N., Ikuta K., Spangrude G.J., Weissman I.L. Functional heterogeneity is associated with the cell cycle status of murine hematopoietic stem cells. J Cell Biol. 122:1993;897-902.
21. McGahon A., Bissonnette R., Schmitt M., Cotter K.M., Green D.R., Cotter T.G. BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. Blood. 83:1994;1179-1187.
22. Sanchez-Garcia I., Grütz G. Tumorigenic activity of the BCR-ABL oncogenes is mediated by BCL2. Proc Natl Acad Sci USA. 92:1995;5287-5291.
23. Shivdasani R.A., Orkin S.H. The transcriptional control of hematopoiesis. Blood. 87:1996;4025-4039.
24. Fujita N., Naito M., Lee S.-H., Hanaoka K., Tsuruo T. Apoptosis inhibition by anti-Mr 23,000 (Thy-1) monoclonal antibodies without inducing bcl-2 expression. Cell Growth Differ. 6:1995;355-362.